Oxcarbazepine Tablet, Film Coated
Product Images NDC 72865-283

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72865-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

A Kaplan-Meier plot showing the exit rate over time on trial from day 2, comparing Oxcarbazepine and placebo treatment groups. The x-axis represents days on trial from day 2 to day 11, and the y-axis shows the exit rate from 0.0 to 1.0. The plot includes a log-rank test p-value of 0.0001, indicating a statistical comparison between the two groups.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A Kaplan-Meier curve depicting seizure rate over time in days from first dose to first seizure, comparing oxcarbazepine treatment versus placebo. The x-axis represents days, and the y-axis represents seizure rate. The graph includes a log-rank test p-value of 0.046 indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier survival curve chart comparing exit rates over time in days for two treatment groups labeled HIGH and LOW. The Y-axis represents the exit rate from 0.0 to 1.0 and the X-axis shows time to exit in days up to 130. A log-rank test p-value of 0.0001 is shown, indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

A survival-type curve graph showing exit rate on the vertical axis and time to exit in days on the horizontal axis. It compares two treatment groups labeled HIGH and LOW, with the LOW group showing a steeper increase in exit rate over time. The graph includes a log-rank test p-value of 0.0001, indicating a statistically significant difference between groups.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure of oxcarbazepine, depicting its molecular arrangement with fused aromatic rings and functional groups including a ketone and an amide.*

FDA Label Image

Oxcarbazipinetab150mglabel (Oxcarbazipinetab150mglabel)

Oxcarbazepine 150 mg tablets label from XLCare Pharmaceuticals Inc., for oral use. The film-coated tablets come in a bottle containing 100 tablets. Label includes storage instructions and pharmacist dispensing guidance, with manufacturer details for XLCare Pharmaceuticals and Evaric Pharmaceuticals.*

FDA Label Image

Oxcarbazipinetab300mglabel (Oxcarbazipinetab300mglabel)

Label for Oxcarbazepine Tablets USP 300 mg, film-coated oral tablets. The label indicates the product contains 100 tablets, is prescription only (Rx only), and is labeled by XLCare Pharmaceuticals Inc. It includes storage instructions, a pharmacist advisory to provide the medication guide, and manufacturer information for Evaric Pharmaceuticals Inc.*

FDA Label Image

Oxcarbazipinetab600mglabel (Oxcarbazipinetab600mglabel)

Label for Oxcarbazepine Tablets, USP 600 mg by XLCare Pharmaceuticals Inc. The label shows a film-coated tablet oral dosage form with a package count of 100 tablets. It includes storage instructions, manufacturer contact information, and dispensing guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.